期刊
NUCLEIC ACIDS RESEARCH
卷 49, 期 D1, 页码 D562-D569出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkaa895
关键词
-
资金
- Cancer CenterAmsterdam stimulation grant [CCA2018-2-19]
- Dutch Cancer Society [KWF-4874, KWF-11038]
- Brain Tumour Charity [488097]
Kinases are a major target for drug development, with KLIFS being a database focusing on kinase structures and interactions to support research. The latest version of KLIFS has integrated approved drugs, extended coverage to atypical kinases, and provided a RESTful API for programmatic access.
Kinases are a prime target of drug development efforts with >60 drug approvals in the past two decades. Due to the research into this protein family, a wealth of data has been accumulated that keeps on growing. KLIFS-Kinase-Ligand Interaction Fingerprints and Structures-is a structural database focusing on how kinase inhibitors interact with their targets. The aim of KLIFS is to support (structure-based) kinase research through the systematic collection, annotation, and processing of kinase structures. Now, 5 years after releasing the initial KLIFS website, the database has undergone a complete overhaul with a new website, new logo, and new functionalities. In this article, we start by looking back at how KLIFS has been used by the research community, followed by a description of the renewed KLIFS, and conclude with showcasing the functionalities of KLIFS. Major changes include the integration of approved drugs and inhibitors in clinical trials, extension of the coverage to atypical kinases, and a RESTful API for programmatic access.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据